Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

ANI Pharma Inc (ANIP)

ANI Pharma Inc (ANIP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 925,706
  • Shares Outstanding, K 12,096
  • Annual Sales, $ 201,580 K
  • Annual Income, $ 15,490 K
  • 60-Month Beta 2.22
  • Price/Sales 4.35
  • Price/Cash Flow 9.76
  • Price/Book 4.22

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/19
See More
  • Average Estimate 1.32
  • Number of Estimates 1
  • High Estimate 1.32
  • Low Estimate 1.32
  • Prior Year 1.17
  • Growth Rate Est. (year over year) +12.82%

Price Performance

See More
Period Period Low Period High Performance
1-Month
64.26 +19.09%
on 09/05/19
77.46 -1.20%
on 09/13/19
+4.48 (+6.22%)
since 08/13/19
3-Month
63.73 +20.08%
on 08/07/19
86.96 -11.99%
on 07/31/19
+5.28 (+7.41%)
since 06/13/19
52-Week
36.92 +107.29%
on 12/24/18
86.96 -11.99%
on 07/31/19
+22.46 (+41.54%)
since 09/13/18

Most Recent Stories

More News
ANI Pharmaceuticals Announces Launch of Vancomycin Hydrochloride for Oral Solution USP, 250mg/5mL

ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq: ANIP) today announced the launch of Vancomycin HCl for Oral Solution, 250mg per 5mL (the generic equivalent to ANI's Vancocin® for Oral Solution). To facilitate...

ANIP : 76.53 (+5.59%)
ANI Pharmaceuticals (ANIP) Q2 Earnings Surpass Estimates

ANI (ANIP) delivered earnings and revenue surprises of 11.63% and -2.24%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

ANIP : 76.53 (+5.59%)
ANI: 2Q Earnings Snapshot

BAUDETTE, Minn. (AP) _ ANI Pharmaceuticals Inc. (ANIP) on Wednesday reported second-quarter profit of $6.6 million.

ANIP : 76.53 (+5.59%)
ANI Pharmaceuticals Reports Second Quarter Results

For the second quarter 2019:

ANIP : 76.53 (+5.59%)
ANI Pharmaceuticals Schedules Conference Call to Discuss Second Quarter and Year-to-Date 2019 Financial Results

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) announced today that the Company plans to release its second quarter and year-to-date 2019 financial results on Wednesday, August 7, 2019, before the opening of...

ANIP : 76.53 (+5.59%)
Ani Pharmaceutic Shares Up 76.5% Since SmarTrend's Buy Recommendation (ANIP)

SmarTrend identified an Uptrend for Ani Pharmaceutic (NASDAQ:ANIP) on January 4th, 2019 at $48.01. In approximately 7 months, Ani Pharmaceutic has returned 76.50% as of today's recent price of $84.74....

ANIP : 76.53 (+5.59%)
Shares of ANIP Up 69.1% Since Uptrend Call on Shares

SmarTrend identified an Uptrend for Ani Pharmaceutic (NASDAQ:ANIP) on January 4th, 2019 at $48.01. In approximately 7 months, Ani Pharmaceutic has returned 69.13% as of today's recent price of $81.20....

ANIP : 76.53 (+5.59%)
Ani Pharmaceutic Has Returned 68.7% Since SmarTrend Recommendation (ANIP)

SmarTrend identified an Uptrend for Ani Pharmaceutic (NASDAQ:ANIP) on January 4th, 2019 at $48.01. In approximately 6 months, Ani Pharmaceutic has returned 68.69% as of today's recent price of $80.99....

ANIP : 76.53 (+5.59%)
74.0% Return Seen to Date on SmarTrend Ani Pharmaceutic Call (ANIP)

SmarTrend identified an Uptrend for Ani Pharmaceutic (NASDAQ:ANIP) on January 4th, 2019 at $48.01. In approximately 6 months, Ani Pharmaceutic has returned 74.05% as of today's recent price of $83.56....

ANIP : 76.53 (+5.59%)
Ani Pharmaceutic Shares Up 63.3% Since SmarTrend's Buy Recommendation (ANIP)

SmarTrend identified an Uptrend for Ani Pharmaceutic (NASDAQ:ANIP) on January 4th, 2019 at $48.01. In approximately 6 months, Ani Pharmaceutic has returned 63.34% as of today's recent price of $78.42....

ANIP : 76.53 (+5.59%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Soft. Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Trade ANIP with:

Business Summary

ANI Pharmaceuticals, Inc. is a specialty pharmaceutical company. It engaged in developing, manufacturing and marketing branded and generic prescription pharmaceuticals. The company offers liquid, powder, oral solid dose, cough/cold products, antacids, laxatives, stomach remedies as well as hydrocortisone...

See More

Key Turning Points

2nd Resistance Point 81.08
1st Resistance Point 78.80
Last Price 76.53
1st Support Level 72.91
2nd Support Level 69.30

See More

52-Week High 86.96
Last Price 76.53
Fibonacci 61.8% 67.84
Fibonacci 50% 61.94
Fibonacci 38.2% 56.04
52-Week Low 36.92

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar